FAACT-Anorexia Cachexia Scale: Cutoff Value for Anorexia Diagnosis in Advanced Non-Small Cell Lung Cancer Patients

被引:10
|
作者
Georgina Turcott, Jenny [1 ]
Onate-Ocana, Luis F. [2 ]
Soca-Chafre, Giovanny [3 ]
Ramirez-Tirado, Laura-Alejandra [3 ]
Flores-Estrada, Diana [1 ]
Lucia Zatarain-Barron, Zyanya [1 ]
Arrieta, Oscar [1 ]
机构
[1] Natl Canc Inst Mexico INCan, Thorac Oncol Unit, Mexico City, DF, Mexico
[2] Natl Canc Inst Mexico INCan, Div Surg, Clin Res Div, Mexico City, DF, Mexico
[3] Natl Canc Inst Mexico INCan, Expt Oncol Lab, Mexico City, DF, Mexico
来源
关键词
QUALITY-OF-LIFE; NUTRITIONAL-STATUS; ASSOCIATION; VALIDATION; ANAMORELIN; PROGNOSIS; THERAPY; DISEASE; IMPACT;
D O I
10.1080/01635581.2018.1506488
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer (LC) has a high rate of anorexia, which negatively affects quality-of-life and prognosis; however prevalence values may vary as per diagnostic test. There is no standard for anorexia diagnosis, currently the anorexia cachexia scale (A/CS) has been proposed as a tool for diagnosing anorexia with a consensus cutoff value of <= 24, nonetheless a validated cutoff value is required. The A/CS was evaluated in advanced Non-Small Cell Lung Cancer (NSCLC) patients to establish a cutoff value. The appetite item from the QLQ-C30 questionnaire and survival served as a standard reference. The cutoff value was associated with clinical and nutritional characteristics along with quality-of-life. Three hundred and twelve (312) NSCLC patients were evaluated. The mean A/CS value was 31 +/- 9 and the identified cutoff value was 32.5 (sensitivity: 80.3% and specificity: 85%). The proportion of anorexia accurately diagnosed with the cutoff value of 24 was 26%, while with 32 it was 50%. The A/CS cutoff value of 32 was associated with clinical parameters, nutritional consumption, and quality-of-life, and independently associated with overall survival. A score of <= 32 in the A/CS is proposed for anorexia diagnosis in order to identify patients at risk of complications involving malnutrition related to LC.
引用
收藏
页码:409 / 417
页数:9
相关论文
共 50 条
  • [1] Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS)
    Thomas W. LeBlanc
    Greg P. Samsa
    Steven P. Wolf
    Susan C. Locke
    David F. Cella
    Amy P. Abernethy
    Supportive Care in Cancer, 2015, 23 : 2341 - 2347
  • [2] Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS)
    LeBlanc, Thomas W.
    Samsa, Greg P.
    Wolf, Steven P.
    Locke, Susan C.
    Cella, David F.
    Abernethy, Amy P.
    SUPPORTIVE CARE IN CANCER, 2015, 23 (08) : 2341 - 2347
  • [3] FAACT- Anorexia Cachexia Scale: Cut-Off Value for the Anorexia Diagnosis in NSCLC Patients
    Turcott, J.
    Ramirez-Tirado, L.
    Onate-Ocana, L.
    Flores-Estrada, D.
    Zatarain-Barron, Z.
    Soca-Chafre, G.
    Arrieta, O.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2097 - S2097
  • [4] Psychometric properties of the FAACT additional concerns subscale (A/CS) for measurement of anorexia in patients with non-small cell lung cancer
    Gelhorn, Heather L.
    Gries, Katharine S.
    Duus, Elizabeth M.
    Bourne, Richard K.
    Friend, John E.
    Speck, Rebecca M.
    Leidy, Nancy K.
    Cella, David
    QUALITY OF LIFE RESEARCH, 2016, 25 : 71 - 71
  • [5] Comprehensive validation of the functional assessment of anorexia/cachexia therapy (FAACT) anorexia/cachexia subscale (A/CS) in lung cancer patients with involuntary weight loss
    Gelhorn, Heather L.
    Gries, Katharine S.
    Speck, Rebecca M.
    Duus, Elizabeth M.
    Bourne, Richard K.
    Aggarwal, Dimple
    Cella, David
    QUALITY OF LIFE RESEARCH, 2019, 28 (06) : 1641 - 1653
  • [6] Comprehensive validation of the functional assessment of anorexia/cachexia therapy (FAACT) anorexia/cachexia subscale (A/CS) in lung cancer patients with involuntary weight loss
    Heather L. Gelhorn
    Katharine S. Gries
    Rebecca M. Speck
    Elizabeth M. Duus
    Richard K. Bourne
    Dimple Aggarwal
    David Cella
    Quality of Life Research, 2019, 28 : 1641 - 1653
  • [7] Megestrol acetate for cachexia and anorexia in advanced non-small cell lung cancer: A randomized study comparing two different doses
    Ulutin, HC
    Arpaci, F
    Pak, Y
    TUMORI, 2002, 88 (04) : 277 - 280
  • [8] Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia
    Salsman, John M.
    Beaumont, Jennifer L.
    Wortman, Katy
    Yan, Ying
    Friend, John
    Cella, David
    SUPPORTIVE CARE IN CANCER, 2015, 23 (05) : 1355 - 1364
  • [9] Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia
    John M. Salsman
    Jennifer L. Beaumont
    Katy Wortman
    Ying Yan
    John Friend
    David Cella
    Supportive Care in Cancer, 2015, 23 : 1355 - 1364
  • [10] Quality of life and anorexia/cachexia in lung cancer: validation of the Spanish version of the FAACT instrument
    Oscar Arrieta
    Julissa Luvián-Morales
    Jenny G. Turcott
    Luis F. Oñate-Ocaña
    Quality of Life Research, 2018, 27 : 2709 - 2718